Sangamo Therapeutics - Chapter 11 Bidding Procedures Summary

Sangamo Therapeutics obtained approval of bidding procedures to sell all or substantially all of its assets, designating Merope Acquisition Sub (with Eli Lilly as guarantor) and Astellas Gene Therapies as stalking horse bidders — each subject to higher or better offers — for their respective asset packages, ahead of an Aug. 4 bid deadline, Aug. 10 auction, and Aug. 20 sale hearing.

Bidding Procedures / Asset Purchase Agreement Summary

Parties Involved

Assets Being Sold

Stalking Horse Bids

Credit Bid

Bid Protections

Designation of Additional Stalking Horse Bidders

Bid Requirements

Minimum Bid / Overbid

Good Faith Deposit

Qualified Bidder

Auction

Selection of the Successful Bid

Backup Bidder

Assumption and Assignment and/or Rejection

Sale Free and Clear

“As Is, Where Is”

Consultation Parties

Sale Hearing

Key Dates